Hong Kong · Delayed Price · Currency is HKD Consun Pharmaceutical Group Company Description
Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
It operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney disease; Gadopentetate Dimeglumine injections for nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; Iopamidol injections for neuroradiology, angiography, and urography; and ultrasonic microbubble contrast agent products.
It also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yuan, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis; Gyn Antidysmenorrheic tablets for irregular menstruation, an irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion to treat staphylococcus aureus, candida albicans, and escherichia coli in the feminine vaginal.
The company offers bone-setting liquid; Yunxiang analgesic tincture to treat rheumatism, common cold, headache, stomachache, cardiodynia, and pain in the gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease; and hepatobiliary products, such as Jigucao, Compound Jigucao, and Qinggan tablets, as well as Jigucao Ganyan and Wujun Zhidan granules.
It also provides gastroenterology, tonics, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People’s Republic of China.
| Country | Cayman Islands |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,164 |
| CEO | Meng An |
Contact Details
Address: 71, Dongpeng Avenue Guangzhou China | |
| Phone | 86 20 8226 4529 |
| Website | chinaconsun.com |
Stock Details
| Ticker Symbol | 1681 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG2524A1031 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Meng An | Chief Executive Officer and Executive Chairman |
| Yujun Chen | Chief Financial Officer |
| Prof. Quan Zhu | Chief Scientist and Executive Director |
| Lei Zhou | Assistant President |
| Yuk Chuen Young | Executive Director |
| Haien Gao | Company Secretary |
| Guorong Guo | Chairman and GM of Guangxi Yulin Pharmaceutical Group Co. Ltd |
| Lianhui Chen | Chairman and GM of Consun Pharmaceutical (Horgos) Co., LTD. |